Add to My Pictures
Multi-cancer detection (MCD) tests that can reliably find precancer or cancer before it is symptomatic have the potential to substantially change cancer screening. Using a single blood draw, these tests may be able to detect the presence of multiple cancer types—including ones without established screening methods. By rigorously evaluating MCD tests and ensuring that the benefits outweigh potential risks, we may be able to take important steps toward ending cancer as we know it today.
This image is part of the NCI Annual Plan and Budget Proposal FY 2024 collection.
See also www.cancer.gov/research/annual-plan.
|Type:||Color, Photo (JPEG format)|
|Source:||National Cancer Institute|
|Creator:||National Cancer Institute|
|Date Created:||September 6, 2022|
|Date Added:||September 9, 2022|
|Reuse Restrictions:||None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above.|